树突状细胞疫苗在膀胱癌免疫治疗中的前景
摘要
树突状细胞疫苗是肿瘤免疫治疗研究的热点之一 ,近几年在接种途径、疫苗制备、免疫安全性等方面遇到了一些问题 ;膀胱肿瘤的特点以及应用卡介苗灌注取得的免疫成效和膀胱癌树突状细胞疫苗的一些研究成果 。
出处
《国外医学（泌尿系统分册）》
2004年第4期443-447,共5页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献24
-
1Lee P,Wang F,Kuniyoshi J,et al.Phase 1 trial of a melanoma vaccine with gp100 (280-288) peptide and tetanus helper peptide in adjuvant:immunologic and clinical outcomes.Clin Cancer Res,2001,7,3012～3024
-
2Knutson KL,Schiffman K,Disis ML.Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T cell immunity in cancer patients.J Clin Invest,2001,104,477～484
-
3Mincheff M,Zoubak S,Altankova I,et al.Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes.Cancer Gene Ther,2003,10(12),907～917
-
4Jaffee EM,Hruban RH,Biedrzycki B,et al.Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer:a phase I trial of safety and immune activation.J Clin Oncol,2001,19,145～156
-
5Hanna MG,Hoover HC,Vermorken JB,et al.Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine:first randomized phase III trials show promise.Vaccine,2001,19,2576～2582
-
6Schneider T,Gerhards R,Kirches E,et al.Preliminary results of active specific immunization with modified tumor cell vaccine in gliobastoma multiforme.J Neurooncol,2001,53,39～46
-
7von Mehren M,Arlen P,Gulley J,et al.The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine(ALVAC-CEA B7.1) in patients with metastatic carcinoma.Clin Cancer Res,2001,7,1181～1191
-
8Mincheff M,Tchakarov S,Zoubak S,et al.Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer:a phase I/II clinical trial.Eur Urol,2000,38,208～217
-
9Banchereau J,Palucka AK,Dhodapkar M,et al.Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitor-derived dendritic cell Vaccine.Cancer Res,2001,61,6451～6458
-
10Sadanga N,Nagashima H,Mashino K,et al.Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas.Clin Cancer Res,2001,7,2277～2284
-
1刘先礼,卫焘.卡介苗灌注预防膀胱肿瘤复发的远期疗效观察[J].中华泌尿外科杂志,1990,11(6):343-344. 被引量：3
-
2吕伟,张珉,王玉明,郑剑.膀胱癌术后卡介苗灌注预防肿瘤复发效果观察[J].工企医刊,2003,16(2):29-29.
-
3杜信毅,李晓东.α-干扰素加卡介苗灌注预防表浅性膀胱癌术后复发疗效观察[J].山东医药,2005,45(14):55-56.
-
4葛永超,冯成海,霍成,陈振光,马长路,张红新.卡介苗灌注预防膀胱肿瘤复发临床观察[J].河南肿瘤学杂志,1993,6(2):135-136.
-
5陈宇.膀胱癌术后卡介苗灌注预防复发的探讨[J].中外医疗,2009,28(12):36-36. 被引量：1
-
6王志清.膀胱癌术后卡介苗灌注预防复发的探讨[J].实用医技杂志,2006,13(23):4174-4174.
-
7卫立辛,钱卫珠,闰振林,王皓,刘彦君,罗明,赵健,施军霞,沈锋,吴孟超,郭亚军.细胞融合大鼠肝癌疫苗制备及免疫相关表型分析[J].中国肿瘤临床,1999,26(3):219-221.
-
8徐令巽,黄雅丽,杨晨,吴关.表浅膀胱肿瘤病人卡介苗灌注前后自然杀伤(NK)细胞水平[J].北京医科大学学报,1990,22(2):113-115.
-
9李玉兰,李桂贤.膀胱癌术后卡介苗灌注的观察及护理[J].济宁医学院学报,2003,26(2):24-24.
-
10林忠应,陈从其.卡介苗灌注对预防膀胱癌术后复发长期疗效的观察[J].中国综合临床,2003,19(12):1106-1107. 被引量：1
